The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001376336p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
27/10/2026
Date registered
Help: Date registered
17/11/2026
Date last updated
Help: Date last updated
17/11/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/11/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Effects of a remotely-delivered self-directed weight loss diet and exercise program for older adults with knee osteoarthritis and overweight or obesity who live in regional, rural, or remote areas
Scientific title
Effects of a remotely-delivered self-directed weight loss diet and exercise program on knee pain and physical function for older adults with knee osteoarthritis and overweight or obesity who live in regional, rural, or remote areas
Additional trial identifiers [1] 318093 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
osteoarthritis 343128 0
Condition category
Condition code
Musculoskeletal 339210 339210 0 0
Osteoarthritis
Diet and Nutrition 339211 339211 0 0
Obesity

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants receive the My Knee RELIEF program, a self-directed online weight loss and exercise website. The intervention lasts six months, with continued website access until 12 months after randomisation. Participants undertake the program independently at home.

The weight loss component comprises three phases:
1. Rapid weight loss: a very low energy diet involving two OptiSlim meal replacements per day, selected from shakes, bars and soups, together with a meal comprising lean protein and non-starchy vegetables. The diet provides approximately 800 kcal/day. This phase continues until participants reach their nominated weight loss goal (5–10% of initial body weight), or for a maximum of 18 weeks, whichever comes first.
2. Transition: a four-week period in which participants gradually reduce from two meal replacements per day to none, while reintroducing carbohydrate-containing foods using low glycaemic index principles.
3. Weight maintenance: guidance on an ongoing healthy eating pattern emphasising protein, low glycaemic index carbohydrates and reduced fat.

Participants are advised to complete home-based strengthening exercises three times per week using resistance exercise bands. They choose three to five lower-limb exercises (at least one from each muscle group) and one upper-limb exercise from the following library:
- Quadriceps: chair stand and sit; knee extension; step up
- Gluteals and hamstrings: bridge; standing side leg raise; standing wall push; crab walk; hamstring curl
- Calves: calf raise; single-leg calf raise; step calf raise
- Upper limb: biceps curl; wall push-up

Each exercise is performed for three sets of ten repetitions, with two minutes’ rest between sets, at moderate intensity (an effort level of 5–6 out of 10, where 10 is maximal effort). Each exercise has a video demonstration and written instructions, including how to increase the challenge (e.g. a firmer resistance band) when it feels too easy, and how to make it easier or leave it out if knee pain increases. An optional physical activity component supports participants to set a daily step goal or other activity goals such as walking, cycling or swimming.

The website provides educational guides for each phase, weekly check-ins, behaviour-change tools and automated email reminders. Behaviour-change tools include: goal setting (e.g., a personal weight loss goal); self-monitoring (e.g., weekly weight logging with progress graphs, and a food and exercise diary); feedback on progress at each check-in; action planning (e.g., weekly meal planner, and IF-THEN plans for high-risk situations); problem solving (e.g., overcoming barriers, identifying eating triggers and habits, hunger scale); reframing all-or-nothing thinking; and relaxation exercises for managing stress and cravings.

An optional AI chatbot answers questions about the program and provides behavioural support, such as helping participants work through barriers to following the diet or exercise program, reflect on motivation and confidence, plan for difficult situations, and get back on track after setbacks. Responses draw on clinician-approved safety scripts, a clinician-developed library of frequently asked questions and program content, and use a motivational interviewing style. The chatbot does not diagnose, prescribe or give individualised medical advice. Questions indicating a possible medical concern trigger pre-written responses directing participants to their GP or emergency services.

There is no set daily time requirement. Intended website use over six months comprises: an introductory guide before starting (about 30 minutes); a guide at the start of each diet phase (about 20–30 minutes each); a brief check-in three days after starting the diet, then weekly check-ins (about 5–10 minutes each); and using the exercise videos and logging exercise sessions three times per week. Other tools, the diary and the chatbot are used as needed.

Meal replacements for the rapid weight loss and transition phases, and resistance exercise bands, are supplied at no cost. The research team will assess engagement and adherence using website activity records and participant self-report.
Intervention code [1] 334978 0
Treatment: Other
Description of the comparator or control
During the six-month intervention period, participants receive access to a self-directed online education website providing general information about knee osteoarthritis and its management. Topics include treatment options, exercise and physical activity, weight management, pain management and sleep, with links to further resources.

Participants use the website independently and as frequently as they choose; there is no prescribed frequency of use. The website provides general education rather than a structured weight loss diet, prescribed exercise program, personalised progression or AI chatbot support. Website login frequency will be recorded to assess engagement.

Participants in both groups may continue to access healthcare outside the trial.
Control group
Active

Outcomes
Primary outcome [1] 347269 0
Knee pain severity over the past week
Timepoint [1] 347269 0
Baseline, 6 (primary endpoint), and 12 months post-randomisation
Primary outcome [2] 347270 0
Physical function
Timepoint [2] 347270 0
Baseline, 6 (primary endpoint), and 12 months post-randomisation
Secondary outcome [1] 469797 0
Body weight
Timepoint [1] 469797 0
Baseline, 6, and 12 months post-randomisation
Secondary outcome [2] 469798 0
Body mass index
Timepoint [2] 469798 0
Baseline, 6, and 12 months post-randomisation
Secondary outcome [3] 469799 0
Pain medication use
Timepoint [3] 469799 0
Baseline, 6, and 12 months post-randomisation
Secondary outcome [4] 469800 0
Physical activity level
Timepoint [4] 469800 0
Baseline, 6, and 12 months post-randomisation
Secondary outcome [5] 469801 0
Health-related quality of life
Timepoint [5] 469801 0
Baseline, 3, 6, 9, and 12 months post-randomisation
Secondary outcome [6] 469802 0
Global rating of change
Timepoint [6] 469802 0
6 and 12 months post-randomisation
Secondary outcome [7] 469803 0
Satisfaction with program
Timepoint [7] 469803 0
6 and 12 months post-randomisation
Secondary outcome [8] 469804 0
Depression
Timepoint [8] 469804 0
Baseline, 6, and 12 months post-randomisation
Secondary outcome [9] 469805 0
Appointment with an orthopaedic surgeon
Timepoint [9] 469805 0
Baseline, 6, and 12 months post-randomisation
Secondary outcome [10] 469808 0
Willingness to undergo knee joint replacement surgery
Timepoint [10] 469808 0
Baseline, 6, and 12 months post-randomisation
Secondary outcome [11] 469809 0
Total joint replacement and knee arthroscopy surgery
Timepoint [11] 469809 0
6 and 12 months post-randomisation

Eligibility
Key inclusion criteria
Participants must:
- Be aged 65 years or older and meet National Institute for Health and Care Excellence clinical criteria for knee osteoarthritis.
- Have knee pain for at least three months, experienced on most days of the past month, and average knee pain intensity of at least 4/10 over the past week.
- Live in regional, rural or remote Australia, defined as Modified Monash Model categories MM2–MM7.
- Have a body mass index of at least 27 kg/m², calculated from self-reported height and weight.
- Have sufficient English fluency to complete questionnaires and engage with the intervention.
- Have access to an internet-connected device and a personal email address that they regularly access.
- Be willing to lose weight and use meal replacements if allocated to My Knee RELIEF.
- Be willing and able to provide informed consent and participate in the intervention and assessment procedures.
- Be willing to provide their general practitioner’s details and permit study personnel to contact their GP regarding trial participation.
Minimum age
65 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants will be excluded for:
- Body weight greater than 150 kg.
- Current or recent regular strengthening exercise for knee problems, defined as at least once weekly within the past six months.
- Being on a waiting list for, or planning, knee, hip or bariatric surgery within the next 12 months.
- Knee surgery within the past six months.
- Weight loss greater than 5 kg within the previous three months.
- Current use of weight loss medication, or planned use within the next six months.
- Conditions preventing participation in a very low energy diet without medical supervision, including self-reported type 1 diabetes; type 2 diabetes requiring medication other than metformin; stroke or a cardiac event within the previous six months; unstable cardiovascular disease; fluid restriction; or kidney problems. People reporting kidney problems may participate if GP clearance is obtained, including confirmation of an estimated glomerular filtration rate greater than 30 mL/min/1.73 m².
- Dietary requirements necessitating individual modification by a dietitian, including a vegan diet or allergy/intolerance to gluten, dairy or soy.
- Participation in a CHESM clinical trial within the previous four years, or current participation in another research study at CHESM or elsewhere.
- Self-reported history of an eating disorder or disordered eating behaviours.
- No access to scales for measuring body weight.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The allocation schedule will be held on a password-protected REDCap website at The University of Melbourne, maintained by a researcher who is not involved in participant recruitment or administration of primary or secondary outcome measures. Participants will be randomised after providing informed consent and completing baseline assessments. Staff determining eligibility and enrolling participants will not have access to upcoming allocations.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
An independent biostatistician will prepare a computer-generated randomisation sequence, allocating participants to the intervention or control group in a 1:1 ratio using randomly permuted blocks of varying sizes.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC

Funding & Sponsors
Funding source category [1] 322651 0
Government body
Name [1] 322651 0
Australian Department of Health, Disability and Ageing, Medical Research Future Fund
Country [1] 322651 0
Australia
Primary sponsor type
University
Name
University of Melbourne
Address
Country
Australia
Secondary sponsor category [1] 325577 0
None
Name [1] 325577 0
Address [1] 325577 0
Country [1] 325577 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 321110 0
University of Melbourne Central Human Research Ethics Committee
Ethics committee address [1] 321110 0
Ethics committee country [1] 321110 0
Australia
Date submitted for ethics approval [1] 321110 0
01/09/2026
Approval date [1] 321110 0
Ethics approval number [1] 321110 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 152698 0
Dr Belinda Lawford
Address 152698 0
Univeristy of Melbourne, 161 Barry St, Carlton, VIC 3010
Country 152698 0
Australia
Phone 152698 0
+61424939907
Fax 152698 0
Email 152698 0
Contact person for public queries
Name 152699 0
Dr Belinda Lawford
Address 152699 0
Univeristy of Melbourne, 161 Barry St, Carlton, VIC 3010
Country 152699 0
Australia
Phone 152699 0
+61424939907
Fax 152699 0
Email 152699 0
Contact person for scientific queries
Name 152700 0
Belinda Lawford
Address 152700 0
Univeristy of Melbourne, 161 Barry St, Carlton, VIC 3010
Country 152700 0
Australia
Phone 152700 0
+61424939907
Fax 152700 0
Email 152700 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: requests directed to Dr Belinda Lawford at [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.